Sérgio Cândido KowalskiJ. A. BenavidesP. A. B. RoaClaudio Galarza-MaldonadoCarlo V. Caballero‐UribeEnrique R. SorianoCarlos PinedaValderílio Feijó AzevedoG. ÁvilaAlejandra Babini2026-03-222026-03-22201910.1007/s10067-019-04496-3https://doi.org/10.1007/s10067-019-04496-3https://andeanlibrary.org/handle/123456789/45639Citaciones: 18enBiosimilarMedicinePharmacovigilanceTraceabilityDelphiDelphi methodFamily medicineActuarial scienceAdverse effectPANLAR consensus statement on biosimilarsarticle